Dennis Ausiello

Dennis Ausiello, is the Director of the Center for Assessment Technology and Continuous Health (CATCH), a program he founded as a joint effort between Massachusetts General Hospital and Massachusetts Institute of Technology (MIT) physicians, scientists and engineers to provide real-time measurement and analysis of the human phenotype in wellness and disease. Dennis previously served as Chief of Medicine at Mass General from 1996 until his retirement in 2013. In this role, he led one of the strongest departments of medicine in the country. Dennis is a nationally recognized leader in academic medicine, having been elected to the Institute of Medicine of the National Academy of Science (1999) and the American Academy of Arts and Sciences (2003). Dennis has written for many publications, including the New York Times and the Wall Street Journal, on various health subjects including human genetics, clinical trials, and the relationship between the academy and industry. As an internationally recognized scientist, with specific expertise in epithelial and membrane biology, ion and water channel regulation and signal transduction, Dennis has served as a council member of the National Institute of Diabetes, the Digestive and Kidney Diseases Advisory Council and the National Advisory Council on Aging. Dennis served as a Member of the Board of Directors at Broad Institute, an independent partnership of Harvard and MIT faculty working in human genetics, as well as the board of directors of the nonprofit organization, Research!America, the leading advocate group for investment in biomedical research in the United States. Understanding the need for partnerships between the academy and industry, Dennis currently serves on the Board of Directors of Pfizer Pharmaceuticals, TARIS, a drug-delivery company, and Alnylam, an iRNA company. Dennis also serves as a Member of the Scientific Advisory Board at BIND Therapeutics. Dennis also serves as an Advisor to various biotech companies and venture capital companies working in the biotech and device area. Dennis holds a B.A. from Harvard College and an M.D. in Medicine from the University of Pennsylvania.